Person

Ronald A. Pankau

Formerly Director, CME Group

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$495K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • CME
    CME Group
    Director
    2016 or earlier – last filing Feb 2020

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 7, 2019CMESale300$199.02$60K
Jun 6, 2019CMESale200$200.36$40K
Mar 1, 2019CMESale200$182.90$37K
Dec 10, 2018CMESale187$190.00$36K
Aug 9, 2018CMESale260$163.17$42K
Jun 7, 2018CMESale250$171.51$43K
Feb 14, 2018CMESale200$159.91$32K
Aug 3, 2017CMESale300$124.78$37K
Feb 24, 2017CMESale500$122.11$61K
Dec 12, 2016CMESale382$123.53$47K
Aug 11, 2016CMESale400$103.32$41K
Feb 26, 2016CMESale200$93.50$19K

SEC reporting-owner ID (CIK) 1523463 · all filings on EDGAR

Ronald A. Pankau | USBoard